Allosteric mechanism for site-specific ubiquitination of FANCD2.

Nat Chem Biol

Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.

Published: March 2020

DNA-damage repair is implemented by proteins that are coordinated by specialized molecular signals. One such signal in the Fanconi anemia (FA) pathway for the repair of DNA interstrand crosslinks is the site-specific monoubiquitination of FANCD2 and FANCI. The signal is mediated by a multiprotein FA core complex (FA-CC) however, the mechanics for precise ubiquitination remain elusive. We show that FANCL, the RING-bearing module in FA-CC, allosterically activates its cognate ubiqutin-conjugating enzyme E2 UBE2T to drive site-specific FANCD2 ubiquitination. Unlike typical RING E3 ligases, FANCL catalyzes ubiquitination by rewiring the intraresidue network of UBE2T to influence the active site. Consequently, a basic triad unique to UBE2T engages a structured acidic patch near the target lysine on FANCD2. This three-dimensional complementarity, between the E2 active site and substrate surface, induced by FANCL is central to site-specific monoubiquitination in the FA pathway. Furthermore, the allosteric network of UBE2T can be engineered to enhance FANCL-catalyzed FANCD2-FANCI di-monoubiquitination without compromising site specificity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035956PMC
http://dx.doi.org/10.1038/s41589-019-0426-zDOI Listing

Publication Analysis

Top Keywords

site-specific monoubiquitination
8
network ube2t
8
active site
8
allosteric mechanism
4
site-specific
4
mechanism site-specific
4
ubiquitination
4
site-specific ubiquitination
4
fancd2
4
ubiquitination fancd2
4

Similar Publications

Article Synopsis
  • RNF168 is an important protein involved in DNA damage repair, specifically regulating how DNA is marked for repair by adding ubiquitin to certain sites on histone H2A.
  • The study developed new chemical strategies and used cryo-electron microscopy to create detailed images of how RNF168 interacts with the E2 enzyme UbcH5c and nucleosomes during this process.
  • It revealed a unique binding mode for RNF168 that differs from other E3 ligases, providing valuable insights into how this protein functions and how mutations may affect its role in DNA repair.
View Article and Find Full Text PDF

Structural inscrutabilities of Histone (H2BK123) monoubiquitination: A systematic review.

Int J Biol Macromol

September 2024

Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi 110062, India. Electronic address:

Histone H2B monoubiquitination in budding yeast is a highly conserved post-translational modification. It is involved in normal functions of the cells like DNA Repair, RNA Pol II activation, trans-histone H3K and H79K methylation, meiosis, vesicle budding, etc. Deregulation of H2BK123ub can lead to the activation of proto-oncogenes and is also linked to neurodegenerative and heart diseases.

View Article and Find Full Text PDF

The Fanconi anemia (FA) repair pathway governs repair of highly genotoxic DNA interstrand crosslinks (ICLs) and relies on translesion synthesis (TLS). TLS is facilitated by REV1 or site-specific monoubiquitination of proliferating cell nuclear antigen (PCNA) (PCNA-Ub) at lysine 164 (K164). A but not mutation renders mammals hypersensitive to ICLs.

View Article and Find Full Text PDF

In Alzheimer's disease and related disorders called tauopathies, the microtubule-associated protein tau accumulates in the brain in the form of amyloid-like supramolecular filaments. As an intrinsically disordered protein, tau undergoes many post-translational modifications, including ubiquitination. Alterations to the levels of ubiquitination of tau have been observed at various stages of neurodegenerative conditions.

View Article and Find Full Text PDF

Fanconi anemia (FA) is a rare genetic disease in which genes essential for DNA repair are mutated. Both the interstrand crosslink (ICL) and double-strand break (DSB) repair pathways are disrupted in FA, leading to patient bone marrow failure (BMF) and cancer predisposition. The only curative therapy for the hematological manifestations of FA is an allogeneic hematopoietic cell transplant (HCT); however, many (>70%) patients lack a suitable human leukocyte antigen (HLA)-matched donor, often resulting in increased rates of graft-versus-host disease (GvHD) and, potentially, the exacerbation of cancer risk.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!